China NMPA Drug Inspection - Anguo Lulutong Traditional Chinese Medicine Pieces Co., Ltd.

The Shandong Provincial Food and Drug Administration announced findings from quality inspections in Issue No. 7, 2018 (published July 4, 2018), revealing that 13 batches of drugs failed quality standards. Inspections by seven drug testing institutions, including the Taian Municipal Food and Drug Inspection and Testing Center, identified substandard products from various manufacturers. These included two batches of finished drugs from companies such as Shanghai Pukang Pharmaceutical Co., Ltd., and eleven batches of traditional Chinese medicine decoction pieces from companies like Anguo Putianhe Traditional Chinese Medicine Pieces Co., Ltd. Operating under the provincial regulatory framework, municipal food and drug administrations initiated immediate control measures. These actions included sealing and seizing the affected products, suspending sales, and issuing recalls. Furthermore, legal cases have been filed against the non-compliant manufacturers and sampled units. Companies are required to investigate the root causes of these quality deficiencies, develop and implement comprehensive rectification plans, and effectively eliminate potential risks to ensure public safety and product integrity.